The handling of antineoplastic drugs has gained another ally. In addition to being simpler, the Closed System transfer device OncoSafe® Arisure ™, tested and approved by the National Institute for Occupational Safety and Health (NIOSH) protocols, arrives in Brazil to support legislation and advice for professionals to reduce exposure to hazardous drugs.
For the posting of the transfer system OncoSafe® Arisure ™, BMR Medical welcomed some of the most prestigious pharmacists and cancer nurses in the country.
According to BMR Medical CEO Rafael Martinelli de Oliveira, the presence of Todd Korogi, CEO of Yukon Medical and Ty Schlander, Director of Business Development at Yukon Medical, represents an important milestone as it consolidates a partnership between BMR Medical and Yukon. Medical for safer treatments.
As for pharmacoeconomics, as the device definition itself indicates, it is the system's task to maintain the microbiological integrity of the drug, whether left over in the vial or at the dose already prepared. Thus, sterility maintenance for up to seven days was attested for all bottle adapters in the line. OncoSafe® Arisure ™.
